Mr. Bosanac, combines over 28 years of experience in capital markets, deal origination, negotiation, corporate advisory, strategy, project implementation, and private and public investment. He has a strong track record in delivering results and his skill sets will help the Company to move towards commercialisation of the MyFiziq app.

Mr Melby brings knowledge and skills to the Board through his experience as an investment banker and private equity professional. Mr Melby has demonstrated success investing in the fitness industry. Mr Melby's experience encompasses operating leading health club brands around the world, finance and digital strategy, business development and international growth.

Mr Prosser has over 20 years of experience in the ICT sector and over 10 years as a founder, entrepreneur,and private investor. Previously he has been involved in Canberra Data Center as a founder and director.

Dato Low has over 30 years' experience in corporate finance, capital markets and M & A. Dato Low, holds multiple offices in both private and public companies. One of which is Singapore listed IEV Holdings. His primary focus as Executive Director of IEV Holdings Limited (SGX: IEV), the Company involved in across the healthcare and wellness sector. Dato Low has been involved in capital market advisory positions across multiple jurisdictions including Australia, Singapore, Malaysia, Hong Kong and the US NASDAQ and NYSE. Dato Low has focuses in restructuring, mergers & acquisitions, and corporate transactions for over 30 years. Over the last 3 decades, he has participated in many corporate transactions in multiple industries and across international borders.

Mr Greissing Jr. is a Strategic Advisor and Senior Fellow with the Milken Institute. Previously he was the Executive Director for the Center of Public Health at the Milken Institute. His work with global business and government leaders, investors, philanthropy, NGOs, and academic thought leaders improves health outcomes for individuals and communities everywhere. Before his time with the Milken Institute, he served as a member of the Executive Committee, Global Leadership Team, and Senior Vice President of Corporate Affairs at Sanofi. During his nearly four decades in the biopharmaceutical industry, Mr Greissing led a range of Public Affairs and Global Corporate Affairs teams, first at the Upjohn Company and Pharmacia and later with Sanofi. Previously he served as President and Chief Executive Officer of Red Line Associates, a consulting firm with clients from the biopharmaceutical, device, food service, and financial industries. Before entering the industry in 1978, Mr Greissing was on the U.S. Senate Intelligence Committee staff, served in the United States Army, and was a military policeman assigned to the Honor Detail at Fort Myer at Arlington Cemetery.

Ms Ingargiola has almost 20 years of experience in public company finance, compliance, capital markets oversight and mergers and acquisitions. She currently serves as Chief Financial Officer of a NASDAQ biotech firm and Audit Chair of several Public companies including AgEagle (NYSE: UAVS), Vision Marine (NASDAQ:VMAR) and Progress Acquisition Corporation (NASDAQ:PGRWU), a new SPAC that recently completed their IPO. She has served multiple public companies in various Officer and Director roles. Ms Ingargiola has helped guide the uplist or IPO of several companies to NASDAQ or the NYSE.

-

-